Sector ratings Perspective Therapeutics, Inc.

Stocks

Real-time Estimate Cboe BZX 12:58:43 19/09/26 am AEST			5-day change	1st Jan Change
2.925 ^USD	+1.56%		+2.49%	+4.73%

19/08	BMO Capital Initiates Perspective Therapeutics at Outperform	MT
14/08	BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
PERSPECTIVE THERAPEUTICS, INC.	329M	-	BBB	-	-
LONZA GROUP AG	46.18B		AAA
IQVIA HOLDINGS INC.	44.35B		AAA
REVOLUTION MEDICINES, INC.	42.21B	-	B	-	-
BEONE MEDICINES AG	40.19B		-
CELLTRION, INC.	29.83B		A
MEDPACE HOLDINGS, INC.	17.17B		BBB
ASCENDIS PHARMA A/S	15.7B	-	-	-	-
EUROFINS SCIENTIFIC SE	15.32B		AA
ICON PUBLIC LIMITED COMPANY	13.09B		AAA
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	13.45B		AA
TEMPUS AI, INC.	14.5B		A		-
BIO-TECHNE CORPORATION	11.36B		AA
PHARMARON BEIJING CO., LTD.	10.98B		AA
KYMERA THERAPEUTICS, INC.	9.85B	-	BBB	-	-
PROTAGONIST THERAPEUTICS, INC.	9.3B		BB		-
ABIVAX	9.38B	-	BBB	-	-
GENSCRIPT BIOTECH CORPORATION	10.82B		AA		-
QIAGEN N.V.	9.18B		AAA
PRAXIS PRECISION MEDICINES, INC.	8.67B	-	B	-	-
Average	18.59B		AA
Weighted average by Cap.			AA